IL273069A - Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement - Google Patents

Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement

Info

Publication number
IL273069A
IL273069A IL273069A IL27306920A IL273069A IL 273069 A IL273069 A IL 273069A IL 273069 A IL273069 A IL 273069A IL 27306920 A IL27306920 A IL 27306920A IL 273069 A IL273069 A IL 273069A
Authority
IL
Israel
Prior art keywords
lipids
carbon atoms
pharmaceutical composition
odd number
nutritional supplement
Prior art date
Application number
IL273069A
Other languages
Hebrew (he)
Original Assignee
Sunregen Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunregen Healthcare Ag filed Critical Sunregen Healthcare Ag
Publication of IL273069A publication Critical patent/IL273069A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL273069A 2017-09-12 2020-03-04 Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement IL273069A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2017/072849 WO2019052629A1 (en) 2017-09-12 2017-09-12 Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement

Publications (1)

Publication Number Publication Date
IL273069A true IL273069A (en) 2020-04-30

Family

ID=59846591

Family Applications (1)

Application Number Title Priority Date Filing Date
IL273069A IL273069A (en) 2017-09-12 2020-03-04 Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement

Country Status (5)

Country Link
BR (1) BR112020004023A2 (en)
EA (1) EA202090566A1 (en)
IL (1) IL273069A (en)
PH (1) PH12020500511A1 (en)
WO (1) WO2019052629A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240307339A1 (en) * 2021-06-18 2024-09-19 Sunregen Healthcare Ag Novel compounds for the treatment and prevention of neurological complications of viral infections
JP2023061448A (en) * 2021-10-20 2023-05-02 リファインホールディングス株式会社 Endoplasmic reticulum stress inhibitor, neurodegenerative disease preventing/improving agent, agent for prevention/progression prevention/improvement of dementia, and food product

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02247125A (en) * 1989-03-17 1990-10-02 Koken Kk Inhibitor of malignant tumor cell multiplication
EP1289530B1 (en) * 2000-06-14 2006-10-04 PORTER, William Leslie Lipids for modulating immune response
KR20030096323A (en) * 2001-04-18 2003-12-24 프로메틱 바이오사이언시즈 인코포레이티드 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
CN101879156B (en) * 2009-05-07 2013-01-30 上海医药工业研究院 Medicinal composition and application thereof
EP2519234B1 (en) * 2009-12-30 2017-06-28 Baylor Research Institute Anaplerotic therapy for alzheimer's disease
US20110301238A1 (en) * 2010-06-02 2011-12-08 Borges Karin Seizure related disorders and therapeutic methods thereof
JP6588903B2 (en) * 2013-11-14 2019-10-09 ザ・ユニバーシティ・オブ・クイーンズランド Neurodegenerative disorders, and treatment and diagnostic methods thereof
CN103641713B (en) * 2013-11-15 2015-10-21 浙江大学 The preparation method of monoglyceride derivative and application
WO2015110977A1 (en) * 2014-01-22 2015-07-30 Rolexi Marketing (Pty) Ltd Fatty acid composition and medicinal use thereof
CA3026152A1 (en) * 2016-06-08 2017-12-14 Sunregen Healthcare Ag Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement

Also Published As

Publication number Publication date
WO2019052629A1 (en) 2019-03-21
BR112020004023A2 (en) 2020-09-08
PH12020500511A1 (en) 2021-05-17
EA202090566A1 (en) 2020-07-14

Similar Documents

Publication Publication Date Title
EP3468551A4 (en) Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
HK1244279A1 (en) Tricyclic compounds and uses thereof in medicine
HK1219026A1 (en) Nutritional compositions containing structured fat globules and uses thereof
EP3325473A4 (en) Compounds and uses thereof in the treatment of cancers and other medical conditions
HK1216702A1 (en) Nutritional compositions containing an enriched lipid fraction and uses thereof
IL247775A0 (en) In vivo and in vitro use of graphene
IL267831A (en) Medicinal compounds and nutritional supplements
HK1245658A1 (en) Nutritional composition useful in the treatment of ibd patients
HK1207966A1 (en) Dietary and nutritional compositions and methods of use
EP3661600A4 (en) Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
EP2994165A4 (en) Nutritional or dietary supplements containing fatty acids and nitrite
SG11201803125XA (en) Nutritional compositions containing butyrate and uses thereof
IL259183B (en) Food supplement and composition for treating the metabolic syndrome
ZA201906237B (en) Applications of spermine and its derivative in preparation of antitumor drug
SG11201803022TA (en) Compositions comprising fatty acids and their use
EP3322785C0 (en) Lubricants with titanium and their use for improving low speed pre-ignition
ZA202000034B (en) Reduction of the content of glycidyl esters in edible oils
GB2568238B (en) Dietary powder composition comprising plant-based sources of fatty acids
EP3278795A4 (en) Uses of hydroxybenzophenone in preparation of antiviral and antitumor drugs
EP3479835A4 (en) Composition for use in improvement of nutritional state
IL273069A (en) Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
PL3658122T3 (en) Pharmaceutical composition comprising sacubitril and valsartan
PL3331377T3 (en) High-energy and protein-enriched nutritional composition
SG11201803025VA (en) Compositions comprising vitamins and their use
SG11201803027PA (en) Compositions comprising phospholipid and their use